Product Images Hizentra
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 46 images provide visual information about the product associated with Hizentra NDC 44206-457 by Csl Behring Ag, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - hizentra 01
Figure 2 - hizentra 02
Figure 3 - hizentra 03
Figure 4 - hizentra 04
Figure 5 - hizentra 05
Figure 6 - hizentra 06
Figure 7 - hizentra 07
Figure 8 - hizentra 08
Figure 9 - hizentra 09
Figure 10 - hizentra 10
Figure 11 - hizentra 11
Figure 12 - hizentra 12
Figure 13 - hizentra 13
Figure 14 - hizentra 14
Figure 15 - hizentra 15
Figure 16 - hizentra 16
Figure 17 - hizentra 17
Figure 18 - hizentra 18
Figure 19 - hizentra 19
Figure 1 - hizentra 20
This appears to be a graph or chart with data points and labels on it. The graph shows some numbers and percentages related to a study, possibly on two different dosages of a medication (0.2 g/kg and 0.4 g/kg of Hizentra) versus a placebo. The numbers may refer to the probability of relapse or withdrawal for each treatment group over a period of time. Without more context or information, it is difficult to provide a full and accurate description of the data.*
Figure 1 - hizentra 21
Figure 2 - hizentra 22
Figure 3 - hizentra 23
Figure 4 - hizentra 24
Figure 5 - hizentra 25
Figure 6 - hizentra 26
Figure 7 - hizentra 27
Figure 8 - hizentra 28
Figure 9 - hizentra 29
Figure 10 - hizentra 30
Figure 11 - hizentra 31
Figure 12 - hizentra 32
Figure 13 - hizentra 33
Figure 14 - hizentra 34
Figure 15 - hizentra 35
Figure 16 - hizentra 36
Figure 17 - hizentra 37
Figure 18 - hizentra 38
Figure 19 - hizentra 39
PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton - hizentra 40
This package contains a single-dose vial of Hizentra® immune globulin subcutaneous (human), which is a 20% liquid solution of human immunoglobulin. The complete directions for use, dosage information, and product compatibility are enclosed in the package insert. There is no preservative present in the solution. It is made from human plasma that may contain infectious agents and viruses, including the causative agent of Creutzfeldt-Jakob disease (CJD). The package insert lists all warnings and precautions associated with the use of Hizentra®. Storage of the product should be at room temperature up to 25°C (77°F) and kept in the original carton. There is a confidential industry program available and distributed by CSL Behring LLC.*
PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - hizentra 41
This is a product description of a 10 mL solution of Immune Globulin Subcutaneous (Human) with complete directions for use contained in the package which also includes single-dose vials. This human plasma-derived product contains no preservative and is 20% liquid. The product may cause CID (Creutzfeldt-Jakob disease) in rare instances and there is a warning and precautions section in the package insert for further information. The product should be stored at room temperature and the expiration date printed on the carton and label should be followed as well as protecting it from light. Any unused or expired product should be discarded along with used disposable supplies. There is a Patient Notification System available with a call to the manufacturer. The product is manufactured and distributed by CSLBehring.*
PRINCIPAL DISPLAY PANEL - 20 mL Vial Carton - hizentra 42
This package appears to contain a medication called "Immune Globulin" in single-dose vials. The solution inside the vial is stable at room temperature for a period indicated by the expiration date. It is meant for subcutaneous administration. The package has directions for use and dosage information. There is also a phone number to enroll in a patient notification system.*
PRINCIPAL DISPLAY PANEL - 50 mL Vial Carton - hizentra 43
This is a description of CSL Behring's Hizentra - a single-dose subcutaneous Immunoglobulin (Human) containing 10g human immune globulin in 50L solution. The storage guidelines indicate that it should be stored at room temperature until the expiration date printed on the carton and the vial label. The package insert should be followed for usage directions, dosage information, and product compatibility. It is also noted that products made from human plasma may contain infectious agents such as viruses, theoretically causing diseases such as Creutzfeld-Jakob disease (CJD). Hence, a warning is given to refer to the package insert's Warnings and Precautions section.*
PRINCIPAL DISPLAY PANEL - 5 mL Syringe Carton - hizentra 44
PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton - hizentra 45
The text contains some unreadable characters, no human understandable text is available.*
PRINCIPAL DISPLAY PANEL - 20 mL Syringe Carton - hizentra 46
This appears to be a medical description with the mentions of various drugs and their administration. The text also includes details about Immune Globulin Subcutaneous, 20% Liquid.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.